Tumor necrosis factors: developments during the last decade - PubMed (original) (raw)

Review

. 1996 Apr-Jun;7(2):93-124.

Affiliations

• PMID: 8688493

Review

Tumor necrosis factors: developments during the last decade

B B Aggarwal et al. Eur Cytokine Netw. 1996 Apr-Jun.

No abstract available

PubMed Disclaimer

Similar articles

• [Tumor necrosis factor and lymphotoxin: endogenous antineoplastic mediators].
  Ketlinskiĭ SA, Belova LA. Ketlinskiĭ SA, et al. Vopr Onkol. 1990;36(4):396-402. Vopr Onkol. 1990. PMID: 2111959 Review. Russian. No abstract available.
• Use of synthetic oligonucleotides for studying gene structure and polymorphism: human genes encoding tumor necrosis factors and their receptors.
  Turetskaya RL, Udalova IA, Kuprash DV, Terskikh AV, Nedopasov SA. Turetskaya RL, et al. Nucleic Acids Symp Ser. 1991;(24):275. Nucleic Acids Symp Ser. 1991. PMID: 1668691 No abstract available.
• Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha.
  Newton RC, Decicco CP. Newton RC, et al. J Med Chem. 1999 Jul 1;42(13):2295-314. doi: 10.1021/jm980541n. J Med Chem. 1999. PMID: 10395470 Review. No abstract available.
• Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
  Marshall WL, Brinkman BM, Ambrose CM, Pesavento PA, Uglialoro AM, Teng E, Finberg RW, Browning JL, Goldfeld AE. Marshall WL, et al. J Immunol. 1999 May 15;162(10):6016-23. J Immunol. 1999. PMID: 10229841

Cited by

• Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations.
  Lasco TM, Yamamoto T, Yoshimura T, Allen SS, Cassone L, McMurray DN. Lasco TM, et al. Infect Immun. 2003 Dec;71(12):7035-42. doi: 10.1128/IAI.71.12.7035-7042.2003. Infect Immun. 2003. PMID: 14638793 Free PMC article.
• _Pediococcus pentosaceus_-Fermented Cordyceps militaris Inhibits Inflammatory Reactions and Alleviates Contact Dermatitis.
  Kwon HK, Song MJ, Lee HJ, Park TS, Kim MI, Park HJ. Kwon HK, et al. Int J Mol Sci. 2018 Nov 7;19(11):3504. doi: 10.3390/ijms19113504. Int J Mol Sci. 2018. PMID: 30405049 Free PMC article.
• TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
  Hamano R, Huang J, Yoshimura T, Oppenheim JJ, Chen X. Hamano R, et al. Eur J Immunol. 2011 Jul;41(7):2010-20. doi: 10.1002/eji.201041205. Eur J Immunol. 2011. PMID: 21491419 Free PMC article.
• Synergistic effects of sequential infection with highly pathogenic porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
  Fan P, Wei Y, Guo L, Wu H, Huang L, Liu J, Liu C. Fan P, et al. Virol J. 2013 Aug 26;10:265. doi: 10.1186/1743-422X-10-265. Virol J. 2013. PMID: 23971711 Free PMC article.
• Moringa oleifera Flower Extract Suppresses the Activation of Inflammatory Mediators in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via NF-κB Pathway.
  Tan WS, Arulselvan P, Karthivashan G, Fakurazi S. Tan WS, et al. Mediators Inflamm. 2015;2015:720171. doi: 10.1155/2015/720171. Epub 2015 Nov 2. Mediators Inflamm. 2015. PMID: 26609199 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database